Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: BIM-23244, a Somatostatin Receptor Subtype 2- and 5-Selective Analog with Enhanced Efficacy in Suppressing Growth Hormone (GH) from Octreotide-Resistant Human GH-Secreting Adenomas1, The Journal of Clinical Endocrinology & Metabolism, January 2001, Endocrine Society,
DOI: 10.1210/jcem.86.1.7099.
You can read the full text:
Contributors
The following have contributed to this page
